17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8546392
APP PUB NO 20100204234A1
SERIAL NO

12593134

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of non-steroidal 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment and prophylaxis of hormone-dependent, particularly estrogen-dependent, diseases. The invention further relates to suitable inhibitors and to a method for the production thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITAET DES SAARLANDESCAMPUS SAARBRUECKEN 66123 SAARBRUECKEN 66123

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Frotscher, Martin Sulzbach, DE 3 82
Hartmann, Rolf Saarbrücken, DE 34 365
Messinger, Josef Hannover, DE 22 249
Oberwinkler, Sandrine Blieskastel, DE 2 82
Thole, Heinrich-Hubert Hannover, DE 10 119
Ziegler, Erika Völklingen, DE 1 77

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 1, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00